L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) Patients
Clinical trial NCT01334892 · TERMINATED
Trial details
- NCT number
- NCT01334892
- Sponsor
- Pari Pharma GmbH
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2013-07-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.